Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.54 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.54 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.54 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | PYGB | P11216 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ribose (Furanose) SCHEMBL15814845 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL14349491 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL447758 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL16199379 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL24087736 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL66645 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL23017520 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL109435 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL12878699 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL7618455 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10588962-B2 | Carbohydrate-glycolipid conjugate vaccines | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-03-17 | — | — | US | claimed |
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-08-27 | — | — | US | claimed |
| US-20150216985-A1 | ENDOSPORE COMPOSITIONS AND USES THEREOF | Annuary Healthcare Inc. | 2015-08-06 | — | — | US | claimed |
| EP-2827899-B1 | POLYSACCHARIDE ANTIGEN-GLYCOLIPID CONJUGATE VACCINES | MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V (DE) | 2015-08-05 | — | — | EP | claimed |
| EP-2827899-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-01-28 | — | — | EP | claimed |
| WO-2013178236-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2013-12-05 | — | — | WO | claimed |
| WO-2013139803-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-09-26 | — | — | WO | claimed |
| US-20120108533-A1 | NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) | 2012-05-03 | — | — | US | claimed |
| CN-101219114-B | Pennogenin compounds solid state molecule dispersion preparation | YUNNAN BAIYAO GROUP CO LTD | 2010-06-02 | — | — | CN | claimed |
| CN-101181288-B | Solid-state molecule disperse preparations of pennogenin series compounds | YUNNAN BAIYAO GROUP CO LTD | 2010-06-02 | — | — | CN | claimed |
| CN-1562064-A | New use of saponin compound for treating cardiovascular disease | CHINESE MEDICINES & NATURAL ME (CN) | 2005-01-12 | — | — | CN | claimed |
| EP-1144425-B1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LAB LTD (IN) | 2004-06-16 | — | — | EP | claimed |
| US-6693178-B2 | HALOGENATED BENZYL ETHER GALACTOPYRANOSIDE, GLUCOPYRANOSIDE, RIBOFURANOSIDE OR XYLOFURANOSIDE DERIVATIVES; STABLE, EASILY REMOVED | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2004-02-17 | — | — | US | claimed |
| CN-1414010-A | Cardiac glycoside type compound for treating carcinosis and its preparation method | SHENZHENG CHINESE MEDICINE AND (CN) | 2003-04-30 | — | — | CN | claimed |
| US-6329344-B1 | UREA DERIVATIVE OF ALKYLENE DIOXYFURAN ETHERS | RANBAXY LABORATORIES LIMITED (IN) | 2001-12-11 | — | — | US | claimed |
| EP-1144425-A1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LABORATORIES, LTD. (IN) | 2001-10-17 | — | — | EP | claimed |
| WO-2000042053-A1 | DERIVATIVES OF MONOSACCHARIDES AS CELL ADHESION INHIBITORS | RANBAXY LABORATORIES LIMITED (US) | 2000-07-20 | — | — | WO | claimed |
| EP-0668866-B1 | ANTI-PROLIFERATIVE AND ANTI-INFLAMMATORY COMPOUNDS: DERIVATIVES OF PENTOSE MONOSACCHARIDES | BOSTON LIFE SCIENCES INC (US) | 1997-07-30 | — | — | EP | claimed |
| EP-0668866-A1 | ANTI-PROLIFERATIVE AND ANTI-INFLAMMATORY COMPOUNDS: DERIVATIVES OF PENTOSE MONOSACCHARIDES. | GREENWICH PHARMA (US) | 1995-08-30 | — | — | EP | claimed |
| WO-1994011381-A1 | ANTI-PROLIFERATIVE AND ANTI-INFLAMMATORY COMPOUNDS: DERIVATIVES OF PENTOSE MONOSACCHARIDES | GREENWICH PHARMACEUTICALS INCORPORATED (US) | 1994-05-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150216985-A1 | ENDOSPORE COMPOSITIONS AND USES THEREOF | CUTA, SUCLG1, CD47 | LGALS1 347/4885LGALS3 368/4885LGALS9 1207/4885 |
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | STT3B, STT3A, DDOST | LGALS1 176/4885LGALS3 119/4885LGALS9 153/4885 |
| US-20120108533-A1 | NOVEL PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS | PNP, TYMP, MTAP | LGALS1 4054/4885LGALS3 4516/4885LGALS9 4192/4885 |
| US-10588962-B2 | Carbohydrate-glycolipid conjugate vaccines | STT3B, STT3A, DDOST | LGALS1 176/4885LGALS3 119/4885LGALS9 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.